Company / Operating Margin
Perspective Therapeutics, Inc. Operating Margin History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-220.6%
FY2022
5-year range
-403.8% / -106.6%
FY2018-FY2022
Trend
-0.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -403.8% in FY2019 to -71.0% in FY2013.
Based on SEC 10-K filings.
-220.6% in FY2022 with a 5-year CAGR of -126.4%.
Improved from -290.7% to -220.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +183.2pp
- 5-Year Change
- -126.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, operating margin decreased 0.1% year-over-year.
- Peak operating margin was recorded in FY2013.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -220.6% | -0.1% |
| FY2021 | -220.4% | +24.2% |
| FY2020 | -290.7% | +28.0% |
| FY2019 | -403.8% | -278.9% |
| FY2018 | -106.6% | -13.2% |
| FY2017 | -94.2% | +13.4% |
| FY2016 | -108.7% | -21.0% |
| FY2015 | -89.9% | +0.0% |
| FY2014 | -89.9% | -26.7% |
| FY2013 | -71.0% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026